市場調查報告書

全球醫藥品隔離器市場:產業趨勢與預測

Global Pharmaceutical Isolator Market - Industry Trends and Forecast to 2026

出版商 Data Bridge Market Research Private Limited 商品編碼 836089
出版日期 內容資訊 英文 283 Pages
商品交期: 最快1-2個工作天內
價格
全球醫藥品隔離器市場:產業趨勢與預測 Global Pharmaceutical Isolator Market - Industry Trends and Forecast to 2026
出版日期: 2019年04月01日內容資訊: 英文 283 Pages
簡介

本報告提供全球醫藥品隔離器市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊。

第1章 簡介

第2章 市場區隔

第3章 市場概要

  • 促進要素
  • 阻礙要素
  • 機會
  • 課題

第4章 摘要整理

第5章 高級見解

第6章 產業趨勢

第7章 各類型市場

  • 概要
  • 無菌隔離器
  • 封鎖型隔離器
  • 生物隔離器
  • 取樣調查及計量隔離器
  • SPI製造隔離器
  • 其他

第8章 產品各級市場

  • 概要
  • III級
  • ISO級

第9章 各系統市場

  • 概要
  • 封閉系統
  • 開放系統

第10章 各壓差市場

  • 概要
  • 正壓
  • 負壓

第11章 各配置市場

  • 概要
  • 地板型
  • 可動型
  • 緊湊型
  • 模組化型
  • 桌面型
  • 可攜式

第12章 各用途市場

  • 概要
  • 無菌實驗
  • 醫藥品產業
  • 微生物安全性機櫃(櫥櫃)
  • 取樣調查/計量/分配
  • 動物實驗室
  • 醫療設備製造
  • 其他

第13章 各終端用戶市場

  • 概要
  • 醫院
  • 診斷測試所
  • 學術研究機關
  • 製藥公司·生物科技企業
  • CRO

第14章 各流通管道市場

  • 概要
  • 直接競標
  • 零售業者

第15章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第16章 企業趨勢

第17章 企業簡介

第18章 結論

第19章 問題事項

第20章 相關報告

目錄

Global pharmaceutical isolator market is projected to register a healthy CAGR of 7.7% in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling and Weighing Isolators, Active Pharmaceutical Ingredient (API) Manufacturing Isolators, Others), Product Class Type (ISO Class 5, Class III), System Type (Open System, Closed System), Pressure Difference (Positive Pressure, Negative Pressure), Configuration (Floor Standing, Mobile, Compact, Modular, Table Top, Portable), Application (Sterility Testing, Pharmaceutical Industry, Microbiology Safety Cabinets, Sampling/ Weighing/ Distribution, Animal Laboratories, Medical Device Manufacturing, Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, Academic and Research Institutes, Hospitals, Diagnostic Laboratories), Distribution Channel (Direct Tender, Retailer), Geography (Europe, North America, Asia-Pacific, South America, Middle East and Africa)

Major growing sectors under the market segmentation are as follows:

  • In type, aseptic isolators segment is dominating the market with largest market share as due to government regulation there is need to maintain the aseptic condition. Because of this reason aseptic isolators are growing with the highest CAGR and also dominating the market.
  • In product class type, ISO Class 5 segment is dominating the market with largest market share as class 5 is cheaper as compare to class 3 and maintains the standard aseptic processing which fulfils the GMP and cGMP regulations. Due to this reasons, ISO Class 5 are growing with the highest CAGR also dominating the market.
  • In pressure difference, positive pressure segment is dominating the market with largest market share as aseptic isolators are designed to provide air tight environment with no contamination which can be best achieved with positive pressure air flow. Positive pressure air flow meets the standard requirement of aseptic processing of sterile drugs, hence preferred mostly by the drugs manufacturers. Due to this reasons, positive pressure segment are growing with the highest CAGR also dominating the market.
  • In system type, open system segment is dominating the market due to allowing for the continuous or semi-continuous ingress and egress of materials during operations through one or more openings. Due to this reasons, open system segment are growing with the highest CAGR also dominating the market.
  • In configuration, floor standing segment is dominating the market with largest market share due to the easy handling and is the traditional configured isolators, which are designed for the production processing of the sterile drugs. However, the mobile segment is growing with the highest CAGR as they are easier to carry and transfer from one room to another room and designed with the advanced feature in terms of battery backup as compare to the floor standing.
  • In application, sterility testing segment is dominating the market with largest market share as the sterility tests are majorly performed for the medical, pharmaceutical and biotechnology industry to obtain the parameters and properties of the sterile drugs and the ingredients and according to the ISO the sterility test is mandate before the marketing of the drugs. Whereas, the majority of the pharmaceutical industries preferring isolators in terms of the contamination free environment and leading the growth of the isolators.
  • In end user, pharmaceutical and biotechnology companies segment is dominating the market with largest market share as pharmaceutical and biotechnology companies need to maintain the aseptic condition so there will be need for the isolator.
  • In distribution channel, direct tender segment is dominating the market as most of consumer prefer online retailing channel.

Market Players::

The key market players for global pharmaceutical isolator market are listed below:

  • Getinge AB
  • Chiyoda Corporation
  • Azbil Corporation
  • Germfree
  • MBRAUN
  • Wabash National Corporation
  • NuAire
  • ITECO s.r.l.
  • COMECER S.p.A.
  • Hosokawa
  • Hecht Technologie GmbH
  • Steriline S.r.l.
  • Envair Limited
  • Vanrx Pharmasystems Inc.
  • TEMA SINERGIE S.p.A
  • SKAN AG
  • Bioquell Inc.
  • I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.
  • JACOMEX
  • Fedegari Autoclavi S.p.A

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL PHARMACEUTICAL ISOLATOR MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 RESEARCH METHODOLOGY
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 DBMR VENDOR SHARE ANALYSIS
  • 2.9 MULTIVARIATE MODELING
  • 2.10 PRODUCTS LIFELINE CURVE
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL SECTOR/INDUSTRY
    • 3.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS
    • 3.1.3 INCREASING REGULATIONS AND COST OF NONCOMPLIANCE
    • 3.1.4 HIGH MAINTENANCE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS
  • 3.2 RESTRAINT
    • 3.2.1 STRINGENT GOVERNMENTAL REGULATIONS
  • 3.3 OPPORTUNITIES
    • 3.3.1 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS
    • 3.3.2 BUSINESS EXPANSION FOR THE PHARMACEUTICAL ISOLATORS
  • 3.4 CHALLENGE
    • 3.4.1 AVAILABILITY OF RESTRICTED ACCESS BARRIER SYSTEMS (RABS) FOR ASEPTIC PROCESSING

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 INDUSTRY INSIGHTS

7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 ASEPTIC ISOLATORS
  • 7.3 CONTAINMENT ISOLATORS
  • 7.4 BIO ISOLATORS
  • 7.5 SAMPLING AND WEIGHING ISOLATORS
  • 7.6 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS
  • 7.7 OTHERS

8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE

  • 8.1 OVERVIEW
  • 8.2 CLASS III
  • 8.3 ISO CLASS 5

9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE

  • 9.1 OVERVIEW
  • 9.2 CLOSED SYSTEM
  • 9.3 OPEN SYSTEM

10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE

  • 10.1 OVERVIEW
  • 10.2 POSITIVE PRESSURE
  • 10.3 NEGATIVE PRESSURE

11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION

  • 11.1 OVERVIEW
  • 11.2 FLOOR STANDING
  • 11.3 MOBILE
  • 11.4 COMPACT
  • 11.5 MODULAR
  • 11.6 TABLE TOP
  • 11.7 PORTABLE

12 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION

  • 12.1 OVERVIEW
  • 12.2 STERILITY TESTING
  • 12.3 PHARMACEUTICAL INDUSTRY
  • 12.4 MICROBIOLOGY SAFETY CABINETS
  • 12.5 SAMPLING/ WEIGHING/ DISTRIBUTION
  • 12.6 ANIMAL LABORATORIES
  • 12.7 MEDICAL DEVICE MANUFACTURING
  • 12.8 OTHERS

13 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY END USER

  • 13.1 OVERVIEW
  • 13.2 HOSPITALS
  • 13.3 DIAGNOSTIC LABORATORIES
  • 13.4 ACADEMIC AND RESEARCH INSTITUTES
  • 13.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 13.6 CONTRACT RESEARCH ORGANIZATION

14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL

  • 14.1 OVERVIEW
  • 14.2 DIRECT TENDER
  • 14.3 RETAILER

15 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY GEOGRAPHY

  • 15.1 OVERVIEW
  • 15.2 NORTH AMERICA
    • 15.2.1 U.S.
    • 15.2.2 CANADA
    • 15.2.3 MEXICO
  • 15.3 EUROPE
    • 15.3.1 GERMANY
    • 15.3.2 FRANCE
    • 15.3.3 ITALY
    • 15.3.4 U.K.
    • 15.3.5 SPAIN
    • 15.3.6 SWITZERLAND
    • 15.3.7 RUSSIA
    • 15.3.8 NETHERLANDS
    • 15.3.9 BELGIUM
    • 15.3.10 TURKEY
    • 15.3.11 REST OF EUROPE
  • 15.4 ASIA-PACIFIC
    • 15.4.1 JAPAN
    • 15.4.2 CHINA
    • 15.4.3 INDIA
    • 15.4.4 SOUTH KOREA
    • 15.4.5 AUSTRALIA
    • 15.4.6 SINGAPORE
    • 15.4.7 MALAYSIA
    • 15.4.8 THAILAND
    • 15.4.9 INDONESIA
    • 15.4.10 PHILIPPINES
    • 15.4.11 REST OF ASIA-PACIFIC
  • 15.5 SOUTH AMERICA
    • 15.5.1 BRAZIL
    • 15.5.2 REST OF SOUTH AMERICA
  • 15.6 MIDDLE EAST AFRICA
    • 15.6.1 SOUTH AFRICA
    • 15.6.2 REST OF MIDDLE EAST & AFRICA

16 GLOBAL PHARMACEUTICAL ISOLATORS MARKET, COMPANY LANDSCAPE

  • 16.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 16.3 COMPANY SHARE ANALYSIS: EUROPE
  • 16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17 COMPANY PROFILE

  • 17.1 SKAN AG
    • 17.1.1 COMPANY SNAPSHOT
    • 17.1.2 SWOT ANALYSIS
    • 17.1.3 COMPANY SHARE ANALYSIS
    • 17.1.4 GEOGRAPHICAL PRESENCE
    • 17.1.5 PRODUCT PORTFOLIO
    • 17.1.6 RECENT DEVELOPMENTS
    • 17.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS
  • 17.2 COMECER S.P.A.
    • 17.2.1 COMPANY SNAPSHOT
    • 17.2.2 SWOT ANALYSIS
    • 17.2.3 COMPANY SHARE ANALYSIS
    • 17.2.4 GEOGRAPHICAL PRESENCE
    • 17.2.5 PRODUCT PORTFOLIO
    • 17.2.6 RECENT DEVELOPMENTS
    • 17.2.7 DATA BRIDGE MARKET RESEARCH ANALYSIS
  • 17.3 GETINGE AB.
    • 17.3.1 COMPANY SNAPSHOT
    • 17.3.2 SWOT ANALYSIS
    • 17.3.3 REVENUE ANALYSIS
    • 17.3.4 COMPANY SHARE ANALYSIS
    • 17.3.5 GEOGRAPHICAL PRESENCE
    • 17.3.6 PRODUCT PORTFOLIO
    • 17.3.7 RECENT DEVELOPMENTS
    • 17.3.8 DATA BRIDGE MARKET RESEARCH ANALYSIS
  • 17.4 WABASH NATIONAL CORPORATION
    • 17.4.1 COMPANY SNAPSHOT
    • 17.4.2 SWOT ANALYSIS
    • 17.4.3 REVENUE ANALYSIS
    • 17.4.4 COMPANY SHARE ANALYSIS
    • 17.4.5 GEOGRAPHICAL PRESENCE
    • 17.4.6 PRODUCT PORTFOLIO
    • 17.4.7 RECENT DEVELOPMENTS
    • 17.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS
  • 17.5 A. ROVANA LTD.
    • 17.5.1 COMPANY SNAPSHOT
    • 17.5.2 PRODUCT PORTFOLIO
    • 17.5.3 RECENT DEVELOPMENTS
  • 17.6 AZBIL CORPORATION
    • 17.6.1 COMPANY SNAPSHOT
    • 17.6.2 REVENUE ANALYSIS
    • 17.6.3 GEOGRAPHICAL PRESENCE
    • 17.6.4 PRODUCT PORTFOLIO
    • 17.6.5 RECENT DEVELOPMENTS
  • 17.7 BIOQUELL INC
    • 17.7.1 COMPANY SNAPSHOT
    • 17.7.2 GEOGRAPHICAL PRESENCE
    • 17.7.3 PRODUCT PORTFOLIO
    • 17.7.4 RECENT DEVELOPMENTS
  • 17.8 CHIYODA CORPORATION
    • 17.8.1 COMPANY SNAPSHOT
    • 17.8.2 REVENUE ANALYSIS
    • 17.8.3 GEOGRAPHICAL PRESENCE
    • 17.8.4 PRODUCT PORTFOLIO
    • 17.8.5 RECENT DEVELOPMENTS
  • 17.9 ENVAIR LIMITED
    • 17.9.1 COMPANY SNAPSHOT
    • 17.9.2 GEOGRAPHICAL PRESENCE
    • 17.9.3 PRODUCT PORTFOLIO
    • 17.9.4 RECENT DEVELOPMENTS
  • 17.10 ESCO GROUP OF COMPANIES
    • 17.10.1 COMPANY SNAPSHOT
    • 17.10.2 GEOGRAPHICAL PRESENCE
    • 17.10.3 PRODUCT PORTFOLIO
    • 17.10.4 RECENT DEVELOPMENT
  • 17.11 FEDEGARI AUTOCLAVI S.P.A
    • 17.11.1 COMPANY SNAPSHOT
    • 17.11.2 GEOGRAPHICAL PRESENCE
    • 17.11.3 PRODUCT PORTFOLIO
    • 17.11.4 RECENT DEVELOPMENT
  • 17.12 GERMFREE
    • 17.12.1 COMPANY SNAPSHOT
    • 17.12.2 PRODUCT PORTFOLIO
    • 17.12.3 RECENT DEVELOPMENTS
  • 17.13 HECHT TECHNOLOGIE GMBH
    • 17.13.1 COMPANY SNAPSHOT
    • 17.13.2 PRODUCT PORTFOLIO
    • 17.13.3 RECENT DEVELOPMENTS
  • 17.14 HOSOKAWA
    • 17.14.1 COMPANY SNAPSHOT
    • 17.14.2 REVENUE ANALYSIS
    • 17.14.3 GEOGRAPHICAL PRESENCE
    • 17.14.4 PRODUCT PORTFOLIO
    • 17.14.5 RECENT DEVELOPMENTS
  • 17.15 ITECO S.R.L.
    • 17.15.1 COMPANY SNAPSHOT
    • 17.15.2 GEOGRAPHICAL PRESENCE
    • 17.15.3 PRODUCT PORTFOLIO
    • 17.15.4 RECENT DEVELOPMENTS
  • 17.16 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.
    • 17.16.1 COMPANY SNAPSHOT
    • 17.16.2 REVENUE ANALYSIS
    • 17.16.3 GEOGRAPHICAL PRESENCE
    • 17.16.4 PRODUCT PORTFOLIO
    • 17.16.5 RECENT DEVELOPMENT
  • 17.17 JACOMEX
    • 17.17.1 COMPANY SNAPSHOT
    • 17.17.2 GEOGRAPHICAL PRESENCE
    • 17.17.3 PRODUCT PORTFOLIO
    • 17.17.4 RECENT DEVELOPMENTS
  • 17.18 MBRAUN
    • 17.18.1 COMPANY SNAPSHOT
    • 17.18.2 GEOGRAPHICAL PRESENCE
    • 17.18.3 PRODUCT PORTFOLIO
    • 17.18.4 RECENT DEVELOPMENTS
  • 17.19 NUAIRE
    • 17.19.1 COMPANY SNAPSHOT
    • 17.19.2 PRODUCT PORTFOLIO
    • 17.19.3 RECENT DEVELOPMENT
  • 17.20 OPTIMA PACKAGING GROUP GMBH / METALL+PLASTIC GMBH
    • 17.20.1 COMPANY SNAPSHOT
    • 17.20.2 GEOGRAPHICAL PRESENCE
    • 17.20.3 PRODUCT PORTFOLIO
    • 17.20.4 RECENT DEVELOPMENTS
  • 17.21 ROBERT BOSCH GMBH
    • 17.21.1 COMPANYSNAPSHOT
    • 17.21.2 REVENUE ANALYSIS
    • 17.21.3 GEOGRAPHICAL PRESENCE
    • 17.21.4 PRODUCT PORTFOLIO
    • 17.21.5 RECENT DEVELOPMENTS
  • 17.22 STERILINE S.R.L.
    • 17.22.1 COMPANY SNAPSHOT
    • 17.22.2 PRODUCT PORTFOLIO
    • 17.22.3 RECENT DEVELOPMENTS
  • 17.23 TAILIN
    • 17.23.1 COMPANY SNAPSHOT
    • 17.23.2 PRODUCT PORTFOLIO
    • 17.23.3 RECENT DEVELOPMENTS
  • 17.24 TEMA SINERGIE S.P.A
    • 17.24.1 COMPANY SNAPSHOT
    • 17.24.2 PRODUCT PORTFOLIO
    • 17.24.3 RECENT DEVELOPMENTS

  • 17.25 VANRX PHARMASYSTEMS INC.
    • 17.25.1 COMPANY SNAPSHOT
    • 17.25.2 PRODUCT PORTFOLIO
    • 17.25.3 RECENT DEVELOPMENTS

18 CONCLUSION

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF TABLES

  • TABLE 1: OPERATING COSTS FOR ASEPTIC PRODUCTION UNDER RABS OR ISOLATOR
  • TABLE 2: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE , 2017-2026 (USD MILLION)
  • TABLE 3: GLOBAL ASEPTIC ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 4: GLOBAL CONTAINMENT ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 5: GLOBAL BIO ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6: GLOBAL SAMPLING AND WEIGHING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7: GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8: GLOBAL OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE , 2017-2026 (USD MILLION)
  • TABLE 10: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY VOLUME, 2017-2026 (THOUSANDS UNIT)
  • TABLE 11: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY ASP, 2017-2026 (USD)
  • TABLE 12: GLOBAL CLASS III IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 13: GLOBAL ISO CLASS 5 IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 14: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 15: GLOBAL CLOSED SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16: GLOBAL OPEN SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 17: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 18: GLOBAL POSITIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19: GLOBAL NEGATIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 21: GLOBAL FLOOR STANDING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 22: GLOBAL MOBILE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23: GLOBAL COMPACT IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 24: GLOBAL MODULAR IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25: GLOBAL TABLE TOP IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26: GLOBAL PORTABLE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 27: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 28: GLOBAL STERILITY TESTING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29: GLOBAL PHARMACEUTICAL INDUSTRY IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 30: GLOBAL MICROBIOLOGY SAFETY CABINETS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31: GLOBAL SAMPLING/ WEIGHING/ DISTRIBUTION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32: GLOBAL ANIMAL LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 33: GLOBAL MEDICAL DEVICE MANUFACTURING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 34: GLOBAL OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 35: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY END USER , 2017-2026 (USD MILLION)
  • TABLE 36: GLOBAL HOSPITALS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 37: GLOBAL DIAGNOSTIC LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 38: GLOBAL ACADEMIC AND RESEARCH INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 39: GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 40: GLOBAL CONTRACT RESEARCH ORGANIZATION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 41: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 42: GLOBAL DIRECT TENDER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 43: GLOBAL RETAILER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 44: GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 45: NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 46: NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 47: NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 48: NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 49: NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 50: NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 51: NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 52: NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 53: NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 54: U.S PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 55: U.S PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 56: U.S PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE , 2017-2026 (USD MILLION)
  • TABLE 57: U.S PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 58: U.S PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 59: U.S PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 60: U.S PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 61: U.S PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 62: CANADA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 63: CANADA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 64: CANADA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 65: CANADA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 66: CANADA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 67: CANADA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 68: CANADA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 69: CANADA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 70: MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 71: MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 72: MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 73: MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 74: MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 75: MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 76: MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 77: MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 78: EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 79: EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 80: EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 81: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 82: EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 83: EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 84: EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 85: EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 86: EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 87: GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 88: GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 89: GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 90: GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 91: GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 92: GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 93: GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 94: GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 95: FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 96: FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 97: FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 98: FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 99: FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 100: FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 101: FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 102: FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 103: ITALY PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 104: ITALY PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 105: ITALY PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 106: ITALY PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 107: ITALY PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 108: ITALY PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 109: ITALY PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 110: ITALY PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 111: U.K. PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 112: U.K. PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 113: U.K. PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 114: U.K. PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 115: U.K. PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 116: U.K. PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 117: U.K. PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 118: U.K. PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 119: SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 120: SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 121: SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 122: SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 123: SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 124: SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 125: SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 126: SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 127: SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 128: SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 129: SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 130: SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 131: SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 132: SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 133: SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 134: SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 135: RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 136: RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 137: RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 138: RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 139: RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 140: RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 141: RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 142: RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 143: NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 144: NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 145: NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 146: NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 147: NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 148: NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 149: NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 150: NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 151: BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 152: BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 153: BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 154: BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 155: BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 156: BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 157: BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 158: BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 159: TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 160: TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 161: TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 162: TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 163: TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 164: TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 165: TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 166: TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 167: REST OF EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 168: ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 169: ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 170: ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 171: ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 172: ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 173: ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 174: ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 175: ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 176: ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 177: JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 178: JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 179: JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 180: JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 181: JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 182: JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 183: JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 184: JAPAN PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 185: CHINA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 186: CHINA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 187: CHINA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 188: CHINA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 189: CHINA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 190: CHINA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 191: CHINA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 192: CHINA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 193: INDIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 194: INDIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 195: INDIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 196: INDIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 197: INDIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 198: INDIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 199: INDIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 200: INDIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 201: SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 202: SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 203: SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 204: SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 205: SOUTH KOREAPHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 206: SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 207: SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 208: SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 209: AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 210: AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 211: AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 212: AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 213: AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 214: AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 215: AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 216: AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 217: SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 218: SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 219: SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 220: SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 221: SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 222: SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 223: SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY END USER,2017-2026 (USD MILLION)
  • TABLE 224: SINGAPORE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 225: MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 226: MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 227: MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 228: MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 229: MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 230: MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 231: MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 232: MALAYSIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 233: THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 234: THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 235: THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 236: THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 237: THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 238: THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 239: THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 240: THAILAND PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 241: INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 242: INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 243: INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 244: INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 245: INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 246: INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 247: INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 248: INDONESIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 249: PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 250: PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 251: PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 252: PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 253: PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 254: PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 255: PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 256: PHILIPPINES PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 257: REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 258: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 259: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 260: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 261: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 262: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 263: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 264: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 265: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 266: SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 267: BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 268: BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 269: BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 270: BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 271: BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 272: BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 273: BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 274: BRAZIL PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 275: REST OF SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 276: MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 277: MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 278: MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 279: MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)
  • TABLE 280: MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 281: MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 282: MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 283: MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 284: MIDDLE EAST AND AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 285: SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 286: SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)
  • TABLE 287: SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE , 2017-2026 (USD MILLION)
  • TABLE 288: SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)
  • TABLE 289: SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)
  • TABLE 290: SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 291: SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 292: SOUTH AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 293: REST OF MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: GEOGRAPHICAL SCOPE
  • FIGURE 3 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: DATA TRIANGULATION
  • FIGURE 4 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: DROC ANALYSIS
  • FIGURE 5 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: GLOBAL VS REGIONAL ANALYSIS
  • FIGURE 6 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: INTERVIEWS BY REGION AND DESIGNATION
  • FIGURE 8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: DBMR MARKET POSITION GRID
  • FIGURE 9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PHARMACEUTICAL ISOLATOR MARKET
  • FIGURE 11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: MARKET SEGMENTATION
  • FIGURE 12 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL AND HIGH MAINTAINACE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS ARE EXPECTED TO DRIVE THE GLOBAL PHARMACEUTICAL ISOLATOR MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 13 ASEPTIC ISOLATOR IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PHARMACEUTICAL ISOLATOR MARKET IN 2019 & 2026
  • FIGURE 14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY TYPE , 2018
  • FIGURE 15 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY PRODUCT CLASS TYPE, 2018
  • FIGURE 16 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, 2018
  • FIGURE 17 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE DIFFERENCE, 2018
  • FIGURE 18 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, 2018
  • FIGURE 19 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, 2018
  • FIGURE 20 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY END USER, 2018
  • FIGURE 21 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, 2018
  • FIGURE 22 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018)
  • FIGURE 23 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY REGION (2018)
  • FIGURE 24 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY REGION (2019 & 2026)
  • FIGURE 25 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY REGION (2018 & 2026)
  • FIGURE 26 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026)
  • FIGURE 27 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018)
  • FIGURE 28 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018)
  • FIGURE 29 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 30 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 31 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026)
  • FIGURE 32 EUROPE PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018)
  • FIGURE 33 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018)
  • FIGURE 34 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 35 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 36 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026)
  • FIGURE 37 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018)
  • FIGURE 38 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018)
  • FIGURE 39 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 40 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 41 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026)
  • FIGURE 42 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018)
  • FIGURE 43 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018)
  • FIGURE 44 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 45 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 46 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019 - 2026)
  • FIGURE 47 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018)
  • FIGURE 48 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018)
  • FIGURE 49 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 50 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 51 MIDDLE EAST AFRICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026)
  • FIGURE 52 GLOBAL PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 53 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 54 EUROPE PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 55 ASIA-PACIFIC PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%)